J3380
HCPCSInj vedolizumab iv 1 mg
Official HCPCS Level II long descriptor
Injection, vedolizumab, intravenous, 1 mg
HCPCS Level II code J3380 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj vedolizumab iv 1 mg
Added to HCPCS: 2016-01-01
Nearby codes in J3
- J3357Ustekinumab sub cu inj, 1 mg
- J3358Ustekinumab, iv inject, 1 mg
- J3360Diazepam injection
- J3373Inj, vancomycin hcl, 10 mg
- J3374Inj, vancomycin (mylan) 10mg
- J3375Inj, vanco (tyzavan) 10mg
- J3376Inj vancomycin (hikma) 10mg
- J3379Inj, valproate sod, 5 mg
- J3385Velaglucerase alfa
- J3386Etuvetidigene autotemecel
- J3387Inj elivaldogene autotemecel
- J3389Topi adm prad zami per treat
- J3391Inj, atidarsagene autotemcel
- J3392Inj, exagamglogene autotem
- J3393Inj, betibeglogene autotemce
- J3394Inj, lovotibeglogene autotem
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.